Organ Preservation Solution Market Forecasts to 2030 – Global Analysis By Solution (University of Wisconsin Solution (UW), Custodiol HTK Solution, Perfadex Solution, Steen Solution, Celsior Solution, Hypothermosol Solution and Other Solutions), Preservati

Organ Preservation Solution Market Forecasts to 2030 – Global Analysis By Solution (University of Wisconsin Solution (UW), Custodiol HTK Solution, Perfadex Solution, Steen Solution, Celsior Solution, Hypothermosol Solution and Other Solutions), Preservation Type (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion and Other Preservation Types), Organ (Kidneys, Liver, Lungs, Heart and Other Organs), End User and by Geography

According to Stratistics MRC, the Global Organ Preservation Solution Market is accounted for $278.64 million in 2023 and is expected to reach $502.85 million by 2030 growing at a CAGR of 8.8% during the forecast period. Organ Preservation Solution has the ability to preserve organ viability during the crucial time between donation and transplantation, organ preservation solutions are essential to transplant medicine. The ideal preservation environment is provided by these specialized solutions, which are made to shield organs from ischemia damage. These solutions aid in preserving cellular integrity and preventing cellular swelling.

According to the estimates by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. Per the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year.

Market Dynamics:

Driver:

Growing numbers of organ transplant operations

The world's organ transplantation rate is increasing at an unstoppable rate due to an increase in chronic diseases that cause organ failure as well as improvements in surgical methods and immunosuppressive medications. Additionally, the growing demand highlights how vital organ preservation solutions are to the survival and success of transplant operations, which in turn drives ongoing research and development endeavors to enhance and optimize these solutions for a variety of organ kinds.

Restraint:

Limited effectiveness of existing preservation methods

The viability of some organs may be limited by some current organ preservation methods, even with advancements in the field, especially when done for prolonged periods of time. Developing universally effective solutions is challenging due to the complexity of various organs and their distinct physiological requirements. Furthermore, a comprehensive grasp of the preservation requirements unique to each organ and continuous research to improve the effectiveness of current formulations are necessary to address this constraint.

Opportunity:

Technological developments in cryopreservation

The organ preservation market is expected to grow as long as cryopreservation technology continues to progress. The prolongation of organ preservation periods and the enhancement of long-term storage feasibility can be possible through advancements in cryoprotectants and freezing techniques. Moreover, this can lead to more flexible organ transplant scheduling and improved logistical management.

Threat:

Inadequate standardization of preservation procedures

The lack of established procedures for organ preservation creates obstacles and risks for the industry. Disparate protocols among healthcare facilities and geographical areas could impede communication and lead to inconsistent preservation results. Additionally, the establishment of widely recognized standards is essential to guaranteeing the dependability and efficiency of organ preservation techniques.

Covid-19 Impact

The market for organ preservation has seen a variety of effects from the COVID-19 pandemic. Organ transplantation procedures have been impacted, which has resulted in a decrease in transplant volumes. These factors include disruptions in healthcare systems, logistical difficulties, and a shift in priorities towards managing the pandemic. Organ transplantation has been hampered by lockdowns, travel restrictions, and limited access to healthcare. Furthermore, research and development for organ preservation solutions have also seen changes in response to the financial strain on healthcare budgets and resources.

The University of Wisconsin Solution (UW) segment is expected to be the largest during the forecast period

It is projected that the University of Wisconsin Solution (UW) segment will command the largest market share. Organ transplants for the kidney, liver, and pancreas are frequently performed using the UW solution, an extremely effective and adaptable organ preservation medium. Because of its osmotic pressure, balanced electrolyte composition, and capacity to reduce cellular edema, it is the recommended option for organ preservation during the crucial time between organ procurement and transplantation. Moreover, its broad acceptance can be attributed to its successful transplantation outcomes, long history of clinical use, and track record of preserving organ viability.

The Specialty Clinics segment is expected to have the highest CAGR during the forecast period

The market for organ preservation is growing at the highest CAGR in specialty clinics. The growth of specialty clinics devoted to organ transplantation and preservation is facilitated by the trend toward more specialized healthcare services as well as the rising need for targeted, patient-centered care. Pre-transplant evaluations, organ preservation techniques, and post-transplant care are just a few of the extensive services provided by these clinics. Additionally, patients are seeking the expertise of specialized clinics, which often offer more efficient and personalized care than traditional hospitals, due to the increasing prevalence of organ failure conditions and advancements in transplantation techniques.

Region with largest share:

In the market for organ preservation solutions, North America holds the largest share. Numerous factors contribute to this dominance, such as a well-developed healthcare system, a high frequency of organ transplant procedures, and ongoing advancements in medical science and technology. Furthermore, the region is at the forefront of the industry because of its strong regulatory environment, large R&D expenditure, and proactive adoption of cutting-edge healthcare solutions.

Region with highest CAGR:

In the market for organ preservation solutions, the Asia-Pacific region has the highest CAGR. A number of factors, including an increase in the prevalence of organ failure conditions, public awareness of organ transplantation, and advancements in healthcare infrastructure, are driving this region's rapid growth. Furthermore, the growing market share in the Asia-Pacific region can be attributed to the growing emphasis on medical tourism as well as advancements in organ preservation techniques.

Key players in the market

Some of the key players in Organ Preservation Solution market include Paragonix Technologies, Inc, Organox Limited, Transmedics, Inc., Bridge to Life Ltd, Transplant Biomedicals, Accord Healthcare Inc., Waters Medical Systems LLC, Preservation Solutions, Inc. and Xvivo Perfusion AB.

Key Developments:

In August 2023, US-based commercial medical group TransMedics Group announced the completion of the full acquisition of Summit Aviation, a premier US charter flight operator. The acquisition establishes TransMedics Aviation as the first integrated national provider of air logistics dedicated exclusively to organ transplantation in the US.

In July 2023, Organox Ltd. raised £25 million in a funding round that will allow the company to expand its operations in the U.S. on the back of significantly increasing demand from transplant centers, Oern Stuge, executive chairman, at Organox told BioWorld. The Oxford, U.K.-based company which makes systems to preserve and transport livers for transplant is also preparing for its eventual listing on Nasdaq, he added.



In March 2023, Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by Signet Healthcare Partners. This growth investment will bolster Paragonix Technologies’ commercial footprint, including its ongoing extension of clinical service offerings and inventory expansion, and will enable the Company to further advance transplant innovations.

Solutions Covered:
• University of Wisconsin Solution (UW)
• Custodiol HTK Solution
• Perfadex Solution
• Steen Solution
• Celsior Solution
• Hypothermosol Solution
• Other Solutions



Preservation Types Covered:
• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Other Preservation Types

Organs Covered:
• Kidneys
• Liver
• Lungs
• Heart
• Other Organs

End Users Covered:
• Organ Transplant Centers
• Hospitals
• Specialty Clinics
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:

- Market share assessments for the regional and country-level segments

- Strategic recommendations for the new entrants

- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030

- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

- Strategic recommendations in key business segments based on the market estimations

- Competitive landscaping mapping the key common trends

- Company profiling with detailed strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements